References
American Society for Human Genetics. (1996). Diagnostic testing for Prader-Willi and Angelman syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee. American Journal of Human Genetics, 58, 1085–1088.
Angelman, H. (1965). “Puppet children”: A report of three cases. Developmental Medicine and Child Neurology, 7, 681–688.
Brannan, C. I., & Bartolomei, M. S. (1999). Mechanisms of genomic imprinting. Current Opinion in Genetics and Development, 9, 164–170.
Brockmann, K., Bohm, R., & Burger, J. (2002). Exceptionally mild Angelman syndrome phenotype associated with an incomplete imprinting defect. Journal of Medical Genetics, 39, e51–e53.
Brunetti-Pierri, N., Berg, J. S., Scaglia, F., et al. (2008). Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nature Genetics, 40, 1466–1471.
Buiting, K. (2010). Prader-Willi syndrome and Angelman syndrome. American Journal of Medical Genetics Part C Seminars Medical Genetics, 154C, 365–376.
Buiting, K., Dittrich, B., Gross, S., et al. (1998). Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: Implications for imprint-switch models, genetic counseling, and prenatal diagnosis. American Journal of Human Genetics, 63, 170–180.
Buntinx, I. M., Henneckam, R. C. M., Brouwer, O. F., et al. (1995). Clinical profile of Angelman syndrome at different ages. American Journal of Medical Genetics, 56, 176–183.
Cassidy, S. B. (2000). Prader-Willi and Angelman syndromes: Sister imprinted disorders. American Journal of Medical Genetics, 97, 136–146.
Cassidy, S. B., & Schwartz, S. (1998). Prader-Willi and Angelman syndromes: Disorders of genomic imprinting. Medicine, 77, 140–151.
Chan, C. T., Clayton-Smith, J., Cheng, X. J., et al. (1993). Molecular mechanisms in Angelman syndrome: A survey of 93 patients. Journal of Medical Genetics, 30, 895–902.
Cheung, S. W., Shaffer, L. G., Richards, C. S., et al. (1997). Prenatal diagnosis of a fetus with a homologous Robertsonian translocation of chromosome 15. American Journal of Medical Genetics, 72, 47–50.
Christianson, A. L., Stevenson, R. E., van der Meyden, C. H., et al. (1999). X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24–q27. Journal of Medical Genetics, 36, 759–766.
Clayton-Smith, J. (1993). Clinical research on Angelman syndrome in the United Kingdom: Observations on 82 affected individuals. American Journal of Medical Genetics, 46, 12–15.
Clayton-Smith, J., & Laan, L. (2003). Angelman syndrome: A review of the clinical and genetic aspects. Journal of Medical Genetics, 40, 87–95.
Clayton-Smith, J., & Pembrey, M. (1992). Angelman syndrome. Journal of Medical Genetics, 29, 412–415.
Engel, E., & Antonarakis, S. E. (2002). Genomic imprinting and uniparental disomy in medicine. Clinical and molecular aspects. New York: Wiley-Liss.
Fang, P., Lev-Lehman, E., Tsai, T. F., et al. (1999). The spectrum of mutations in UBE3A causing Angelman syndrome. Human Molecular Genetics, 8, 129–135.
Fridman, C. (2000). Origin of uniparental disomy 15 in patients with Prader-Willi or Angelman syndrome. American Journal of Medical Genetics, 94, 249–253.
Fryburg, J. S., Breg, W. R., & Lindgren, V. (1991). Diagnosis of Angelman syndrome in infants. American Journal of Medical Genetics, 38, 58–64.
Gilbert, H. L., Buxton, J. L., Chan, C. T., et al. (1997). Counselling dilemmas associated with the molecular characterization of two Angelman syndrome families. Journal of Medical Genetics, 34, 651–655.
Gilfillan, G. D., Selmer, K. K., Roxrud, I., et al. (2008). SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. American Journal of Human Genetics, 82, 1003–1010.
Gitiaux, C., Ceballos-Picot, I., Marie, S., et al. (2009). Misleading behavioural phenotype with adenylosuccinate lyase deficiency. European Journal of Human Genetics, 17, 133–136.
Glenn, C. C., Deng, G., Michaelis, R. C., et al. (2000). DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting. Prenatal Diagnosis, 20, 300–306.
Glenn, C. C., Saitoh, S., Jong, M. T. C., et al. (1996). Expression, DNA methylation, and gene structure of the human SNRPN gene. American Journal of Human Genetics, 58, 335–346.
Gyftodimou, J. (1999). Angelman syndrome with uniparental disomy due to paternal meiosis II nondisjunction. Clinical Genetics, 55, 483–486.
Horsthemke, B., Maat-Kievit, A., Sleegers, E., et al. (1996). Familial translocations involving 15q11–q13 can give rise to interstitial deletions causing Prader-Willi or Angelman syndrome. Journal of Medical Genetics, 33, 848–851.
Khan, N. L. (1999). Prader-Willi and Angelman syndromes: Update on genetic mechanisms and diagnostic complexities. Current Opinion in Neurology, 12, 149–154.
Kishino, T., Lalande, M., & Wagstaff, J. (1997). UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genetics, 15, 70–73.
Knoll, J. H. M., Nicholls, R. D., Magenis, R. R., et al. (1989). Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. American Journal of Medical Genetics, 32, 285–290.
Kokkonen, H., & Leisti, J. (2000). An unexpected recurrence of Angelman syndrome suggestive of maternal germ-line mosaicism of del(15)(q11q13) in a Finnish family. Human Genetics, 107, 83–85.
Laan, L. A. (1999). Angelman syndrome: A review of clinical and genetic aspects. Clinical Neurology and Neurosurgery, 101, 161–170.
Lalande, M. (1999). Parental imprinting and Angelman syndrome. Advances in Neurology, 79, 421–429.
Ledbetter, D., & Niikawa, N. (1994). Molecular and clinical study of 61 Angelman syndrome patients. American Journal of Medical Genetics, 52, 158–163.
Lossie, A. C., & Driscoll, D. J. (1999). Transmission of Angelman syndrome by an affected mother. Genetics in Medicine, 1, 262–266.
Lossie, A. C., Whitney, M. M., Amidon, D., et al. (2001). Distinct phenotypes distinguish the molecular classes of Angelman syndrome. Journal of Medical Genetics, 38, 834–845.
Malzac, P., Webber, H., Moncla, A., et al. (1998). Mutation analysis of UBE3A in Angelman syndrome patients. American Journal of Human Genetics, 62, 1353–1360.
Moncla, A., Malzac, P., Livet, M. O., et al. (1999). Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: Clinical manifestations and genetic counselling. Journal of Medical Genetics, 36, 554–560.
Nicholls, R. D. (1993). Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: A review. American Journal of Medical Genetics, 46, 16–25.
Nicholls, R., Saitoh, S., & Horsthemke, B. (1998). Imprinting in Prader-Willi and Angelman syndromes. Trends in Genetics, 14, 194–200.
Ohta, T., Buiting, K., Kokkonen, H., et al. (1999). Molecular mechanism of Angelman syndrome in two large families involves an imprinting mutation. American Journal of Human Genetics, 64, 385–386.
Peippo, M. M., Simola, K. O., Valanne, L. K., et al. (2006). Pitt-Hopkins syndrome in two patients and further definition of the phenotype. Clinical Dysmorphology, 15, 47–54.
Petersen, M. B., Brondum-Nielsen, K., Hansen, L. K., et al. (1995). Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: Estimated prevalence rate in a Danish county. American Journal of Medical Genetics, 60, 261–262.
Precht, K. S., Lese, C. M., Spiro, R. P., et al. (1998). Two 22q telomere deletions serendipitously detected by FISH. Journal of Medical Genetics, 35, 939–942.
Ramsden, S. C., Clayton-Smith, J., Birch, R., et al. (2010). Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes. BMC Medical Genetics, 11, 70–96.
Rougeulle, C., Glatt, H., & Lalande, M. (1997). The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nature Genetics, 17, 14–15.
Saitoh, S., Harada, N., Jinno, Y., et al. (1994). Molecular and clinical study of 61 Angelman syndrome patients. American Journal of Medical Genetics, 52, 158–163.
Sharkey, F. H., Morrison, N., Murray, R., et al. (2009). 17q21.31 microdeletion syndrome: Further expanding the clinical phenotype. Cytogenetic and Genome Research, 127, 61–66.
Smith, J. C. (2001). Angelman syndrome: Evolution of the phenotype in adolescents and adults. Developmental Medicine and Child Neurology, 43, 476–480.
Spiegel, E. K., Colman, R. F., & Patterson, D. (2006). Adenylosuccinate lyase deficiency. Molecular Genetics and Metabolism, 89, 19–31.
Stalker, H. J., & Williams, C. A. (1998). Genetic counseling in Angelman syndrome: The challenges of multiple causes. American Journal of Medical Genetics, 77, 54–59.
Stalker, H. J., Williams, C. A., & Wagstaff, J. (1998). Genetic counseling in Angelman syndrome: Gonadal mosaicism. American Journal of Medical Genetics, 78, 482.
Steffenburg, S., Gillberg, C. L., Steffenburg, U., et al. (1996). Autism in Angelman syndrome: A population-based study. Pediatric Neurology, 14, 131–136.
Tsai, T. F., Raas-Rothschild, A., Ben-Neriah, Z., et al. (1998). Prenatal diagnosis and carrier detection for a point mutation in UBE3A causing Angelman syndrome. American Journal of Human Genetics, 63, 1561–1563.
van Bon, B. W., Koolen, D. A., Brueton, L., et al. (2010). The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype. European Journal of Human Genetics, 18, 163–170.
Van Buggenhout, G., & Fryns, J.-P. (2009). Angelman syndrome (AS, MIM 105830). European Journal of Human Genetics, 17, 1367–1373.
Van Lierde, A., Atza, M. G., Giardino, D., et al. (1990). Angelman’s syndrome in the first year of life. Developmental Medicine and Child Neurology, 32, 1011–1016.
Webb, T., Malcolm, S., Pembrey, M. E., et al. (1993). Inheritance of parental chromosomes 15 in Angelman syndrome-implications for the family. Genetic Counsel, 4, 1–6.
Willems, R. J., Dijkstra, I., Brouwer, O. F., et al. (1987). Recurrence risk in the Angelman (“happy puppet”) syndrome. American Journal of Medical Genetics, 27, 773–780.
Williams, C. A. (2001). Angelman syndrome. In S. B. Cassidy & J. E. Allanson (Eds.), Management of genetic syndromes. New York: Wiley-Liss.
Williams, C. A., Angelman, H., Clayton-Smith, J., et al. (1995). Angelman syndrome: Consensus for diagnostic criteria. American Journal of Medical Genetics, 56, 237–238.
Williams, C. A., Beaudet, A. L., Clayton-Smith, J., et al. (2006). Angelman syndrome 2005: Updated consensus for diagnostic criteria. American Journal of Medical Genetics. Part A, 140, 413–418.
Williams, C. A., Dagli, A. I., Driscoll, D. J. Angelman syndrome. GeneReviews. Updated September 5, 2008. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=angelman
Williams, C. A., Driscoll, D. J., & Dagli, A. I. (2010a). Clinical and genetic aspects of Angelman syndrome. Genetics in Medicine, 12, 385–395.
Williams, C. A., Lossie, A., & Driscoll, D. (2001). Angelman syndrome: Mimicking conditions and phenotypes. American Journal of Medical Genetics, 101, 59–64.
Williams, S. R., Mullegama, S. V., Rosenfeld, J. A., et al. (2010b). Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. European Journal of Human Genetics, 18, 436–441.
Williams, C. A., Zori, R. T., Hendrickson, J. E., et al. (1995). Angelman syndrome. Current Problems in Pediatrics, 25, 216–231.
Y-h, J., Lev-Lehman, E., Bressler, J., et al. (1999). Genetics of Angelman syndrome. American Journal of Human Genetics, 65, 1–6.
Yu, T. H., & Hoffman, A. R. (1997). Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nature Genetics, 17, 12–13.
Zweier, C., Peippo, M. M., Hoyer, J., et al. (2007). Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). American Journal of Human Genetics, 80, 994–1001.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this entry
Cite this entry
(2012). Angelman Syndrome. In: Chen, H. (eds) Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1037-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1037-9_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1036-2
Online ISBN: 978-1-4614-1037-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences